Chemotherapeutic Potential of 17-AAG against Cutaneous Leishmaniasis Caused by Leishmania (Viannia) braziliensis

BACKGROUND: Leishmaniasis remains a worldwide public health problem. The limited therapeutic options, drug toxicity and reports of resistance, reinforce the need for the development of new treatment options. Previously, we showed that 17-(allylamino)-17-demethoxygeldanamycin (17-AAG), a Heat Shock P...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Diego M., Petersen, Antonio L. O. A., Celes, Fabiana S., Borges, Valeria M., Veras, Patricia S. T., de Oliveira, Camila I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207694/
https://www.ncbi.nlm.nih.gov/pubmed/25340794
http://dx.doi.org/10.1371/journal.pntd.0003275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207694/
https://www.ncbi.nlm.nih.gov/pubmed/25340794
http://dx.doi.org/10.1371/journal.pntd.0003275

Ejemplares similares